Plasma total homocysteine and hemodialysis access thrombosis: A prospective study

Journal of the American Society of Nephrology

Volumn 10, Issue 5, 1999, Pages 1095-1099

  Shemin, Douglas ^a   Lapane, Kate L ^b   Bausserman, Linda ^c   Kanaan, Elias ^a   Kahn, Sewell ^a   Dworkin, Lance ^a   Bostom, Andrew G ^d  

^a RHODE ISLAND HOSPITAL   (United States)

^b BROWN UNIVERSITY   (United States)

^c MIRIAM HOSPITAL   (United States)

^d MEMORIAL HOSPITAL OF RHODE ISLAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HOMOCYSTEINE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEMODIALYSIS; HUMAN; HYPERHOMOCYSTEINEMIA; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; THROMBOSIS; VASCULAR ACCESS;

EID: 0032905869     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Fan PY, Schwab SJ: Vascular access: Concepts for the 1990s. J Am Soc Nephrol 3: 1-11, 1992
2. Feldman HI, Kobrin S, Wasserstein A: Hemodialysis vascular access morbidity. J Am Soc Nephrol 7: 523-535, 1996
3. Woods JD, Turenne MN, Strawderman RL, Young EW, Hirth RA, Port FK, Held PJ: Vascular access survival among incident hemodialysis patients in the United States. Am J Kidney Dis 30: 50-57, 1997
4. Windus DW, Jemdrisak MD, Delmez JA: Prosthetic fistula survival and complications in hemodialysis patients: Effects of diabetes and age. Am J Kidney Dis 19: 448-452, 1992
5. Mudd SH, Skovby F, Levy HL, Pettigrew KD, Wilcken B, Pyeritz RE: The natural history of homocystinuria due to cystathionine beta synthase deficiency. Am J Hum Genet 37: 1-31, 1985
6. Fermo I, Vigano'D'Angelo S, Paroni R, Mazzola, G, Calori G, D'Angelo A: Prevalence of moderate hyperhomocysteinemia in patients with early-onset venous and arterial occlusive disease. Ann Intern Med 123: 747-753, 1995
7. den Heijer M, Blom HJ, Gerrits WBJ, Rosendaal FR, Haak HL, Wijermans PW, Bos GMJ: Is hyperhomocysteinemia a risk factor for recurrent venous thrombosis? Lancet 345: 882-885, 1995
8. den Heijer M, Koster T, Blom HJ, Bos GMJ, Briet E, Reitsma PH: Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. N Engl J Med 334: 759-762, 1996
9. Petri M, Roubenoff R, Dallal GE, Nadeau MR, Selhub J, Rosenberg IH: Plasma homocysteine as a risk factor for atherothrombotic events in systemic lupus erythematosus. Lancet 348: 1120-1124, 1996
10. Ridker PM, Hennekens CH, Selhub J, Miletich JP, Malinow MR, Stampfer MJ: Interrelation of hyperhomocysteinemia, factor V Leiden, and risk of future venous thromboembolism. Circulation 95: 1777-1782, 1997
11. Bostom AG, Lathrop L: Hyperhomocysteinemia in end-stage renal disease: Prevalence, etiology, and potential relationship to arteriosclerotic outcomes. Kidney Int 52: 10-20, 1997
12. Ducloux D, Pascal B, Jamali M, Gibey R, Chalopin J-M: Is hyperhomocysteinemia a risk factor for recurrent vascular access thrombosis in hemodialysis patients? Nephrol Dial Transplant 12: 2037-2038, 1997
13. Tamura T, Bergman SM, Morgan SL: Homocysteine. B-vitamins, and vascular access thrombosis in patients treated with hemodialysis. Am J Kidney Dis 32: 475-481, 1998
14. Excerpts from the United States Renal Data System 1998 Annual Report. Am J Kidney Dis 32[Suppl 1]: S1-S162, 1998
15. Bostom AG, Shemin D, Lapane KL, Nadeau MR, Sutherland P, Chan J: Folate status is the major determinant of fasting plasma total homocysteine levels in maintenance dialysis patients. Atherosclerosis 123: 193-202, 1996
16. Bostom AG, Shemin D, Verhoef P, Nadeau MR, Jacques PF, Selhub J: Elevated fasting total plasma homocysteine levels and cardiovascular disease outcomes in maintenance dialysis patients: A prospective study. Arterioscler Thromb Vasc Biol 17: 2554-2558, 1997
17. Jungers P, Chauveau P, Bandin O, Chadefaux B, Aupetit J, Labrunie M: Hyperhomocysteinemia is associated with atherosclerotic occlusive arterial accidents in predialysis chronic renal failure patients. Miner Electrolyte Metab 23: 170-173, 1997
18. Moustapha A, Naso A, Nahlawi M, Gupta A, Arheart KL, Jacobsen DW: Prospective study of hyperhomocysteinemia as an adverse cardiovascular risk factor in end-stage renal disease. Circulation 97: 138-141, 1998
19. McCully KS: Vascular pathology of homocysteinemia: Implications for the pathogenesis of arteriosclerosis. Am J Pathol 56: 111-128, 1969
20. Selhub J, D'Angelo A: Hyperhomocysteinemia and thrombosis: Acquired conditions. Thromb Hemost 78: 527-531, 1997
21. Rolland PH, Friggi A, Barlaiter A, Piquet P, Latrille V, Faye MM: Hyperhomocysteinemia-induced vascular damage in the minipig. Circulation 91: 1161-1174, 1995
22. Bostom AG, Shemin D, Lapane KL, Hume AL, Yoburn D, Nadeau MR: High dose B-vitamin treatment of hyperhomocysteinemia in dialysis patients. Kidney Int 49: 147-152, 1996